Application 020356
- Type
- NDA
- Sponsor
- COVIS PHARMA BV
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 005 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 34MG | Yes | Yes |
| 006 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 25.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 007 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 17MG | Yes | Yes |
| 008 | SULAR | NISOLDIPINE | TABLET, EXTENDED RELEASE;ORAL | 8.5MG | Yes | Yes |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0677-1978 | Nisoldipine | Nisoldipine | United Research Laboratories, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0677-1979 | Nisoldipine | Nisoldipine | United Research Laboratories, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0677-1980 | Nisoldipine | Nisoldipine | United Research Laboratories, Inc. | NDA AUTHORIZED GENERIC | Current |
| 0677-1981 | Nisoldipine | Nisoldipine | United Research Laboratories, Inc. | NDA AUTHORIZED GENERIC | Current |
| 59630-500 | SULAR | Nisoldipine | Shionogi Inc. | NDA | Current |
| 59630-501 | SULAR | Nisoldipine | Shionogi Inc. | NDA | Current |
| 59630-503 | SULAR | Nisoldipine | Shionogi Inc. | NDA | Current |
| 66993-472 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-472 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-473 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-473 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-475 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 66993-475 | Nisoldipine | Nisoldipine | Prasco Laboratories | NDA AUTHORIZED GENERIC | Current |
| 70515-500 | Sular | nisoldipine | Covis Pharma | NDA | Current |
| 70515-500 | Sular | nisoldipine | Covis Pharma US, Inc | NDA | Current |
| 70515-500 | Sular | nisoldipine | Covis Pharma | NDA | Current |
| 70515-501 | Sular | nisoldipine | Covis Pharma | NDA | Current |
| 70515-501 | Sular | nisoldipine | Covis Pharma US, Inc | NDA | Current |
| 70515-501 | Sular | nisoldipine | Covis Pharma | NDA | Current |
| 70515-503 | Sular | nisoldipine | Covis Pharma | NDA | Current |
| 70515-503 | Sular | nisoldipine | Covis Pharma US, Inc | NDA | Current |
| 70515-503 | Sular | nisoldipine | Covis Pharma | NDA | Current |